Dosing and Administration# Semaglutide# Wegovy (obesity) : 0.25 mg weekly, titrate monthly to 2.4 mg over 16 weeks Ozempic (T2D) : 0.25 mg weekly, titrate to 0.5 mg, max 2.0 mg Rybelsus (T2D) : 3 mg daily oral, escalate to 7 mg, max 14 mg Oral semaglutide 25 mg (approved 2025): Oral for weight management 52 injections per year (injectable) or daily oral Zovaglutide# Phase 2 tested 80 mg and 160 mg at Q4W (monthly) and Q2W (biweekly) intervals Monthly dosing (Q4W): 12-13 injections per year Biweekly dosing (Q2W): 26 injections per year Final dose and schedule will be determined by Phase 3 No oral formulation The monthly dosing proposition is zovaglutide's most compelling differentiator
Ozempic primarily addresses physiological hunger signals but may have limited impact on emotional eating, stress-related food cravings, or habitual eating patterns
The results found increased bone mineral density resulting from enhanced bone growth and improved bone dimensions [2]
Unlike semaglutide and tirzepatide (which could be compounded during shortages), retatrutide has never been FDA-approved
70,71 Additionally, ASOs can form a double-stranded structure complementary to miRNA, leading to its degradation and causing gene upregulation
A., Tobin, J